Recruiting NA INTERVENTIONAL 2-arm
NCT07452562
Hesperidin RCT in MS (NECTAR-MS)
A Randomized, Placebo-Controlled Trial of Hesperidin for Fatigue,Mood, and Cognitive Function in Multiple Sclerosis
Sponsor: BioActor B.V.
Conditions
Multiple Sclerosis
Interventions
Hesperidin Placebo
Updated 1 time since 2026 Last updated: Feb 28, 2026 Started: Jan 7, 2026 Primary completion: Jan 18, 2027 Completion: Jan 18, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Multiple Sclerosis, this trial is actively recruiting participants. The trial is conducted by BioActor B.V. and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- BioActor B.V.
- Swansea University
Data source: Swansea University
For direct contact, visit the study record on ClinicalTrials.gov .